3649 results for «2568»

Filter By

3649 results

Complex left main PCI - Session with LIVE case

15 Dec 2022 – From GulfPCR-GIM 2022

Follow the discussion around the case presented LIVE in this GulfPCR-GIM 2022 session of a 68-year-old male patient with DM, HTN and hyperlipidaemia, who presented with constant exertional chest pain with class 3 angina for several weeks, and find out more about complex LM PCI.

Complex left main PCI

Severe mitral and tricuspid regurgitation

15 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session aims to illustrate the role of mitral TEER in patients with significant MR and cardiogenic shock, to demonstrate the importance of early detection, but also to show that earlier referral and treatment of patients with significant TR is essential to prevent patients...

Severe mitral and tricuspid regurgitation

Gulf WIN - Opportunities and challenges

15 Dec 2022 – From GulfPCR-GIM 2022

Women have the floor in this special GulfPCR-GIM 2022 session: hear from members of the Gulf WIN (Women In Intervention) to better understand the status of women interventionists in the region, explore the challenges they face, and note the differences that exist with other women cardiologists...

Gulf WIN - Opportunities and challenges

Optimal management of a patient with calcified lesions - Session with LIVE case

15 Dec 2022 – From GulfPCR-GIM 2022

Watch the case of an 87-year-old male patient with DM, HTN, and hyperlipidemia, who suffered ACS six weeks ago, whose culprit lesions were treated in the RCA and LCX, and who was incidentally readmitted for LAD PCI, and find out how he was treated LIVE.

Optimal management of a patient with calcified lesions

Essential drugs that every interventionalist needs to know

15 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, learn about the role of PCSK9 inhibitors in ACS and post-PCI patients, the role of SGLT2 receptor blockers and GLP RAs, and the role of P2Y12 inhibitors as unique post-PCI antiplatelet agents.

Essential drugs that every interventionalist needs to know

CABG vs. PCI - Multivessel disease

15 Dec 2022 – From GulfPCR-GIM 2022

Watch this GulfPCR-GIM 2022 session to find out more about the guidelines in revascularisation for multivessel disease, simplification of multivessel disease PCI using physiological guidance, and much more!

CABG vs. PCI - Multivessel disease

All you need to know on physiology: a 2023 update

15 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, listen to William Wijns discuss the following physiology topics: long-term data on PCI deferral, update on new "negative" studies, low adoption in daily practice, and computational image-based physiology.    

All you need to know on physiology: a 2023 update

Challenging and complication cases

15 Dec 2022 – From GulfPCR-GIM 2022

Watch this GulfPCR-GIM 2022 session to learn how to deal with post-infarction ventricular rupture, an unusual post-CABG complication, a left main complication with the LACOSTE technique, the entrapment of a knotted catheter in the radial artery during primary PCI, and much more!

Challenging and complication cases

GulfPCR-GIM 2022 - Closing Ceremony

15 Dec 2022 – From GulfPCR-GIM 2022

Listen to the Course Directors thank all the participants and take stock of this 2022 edition, insisting in particular on the role of imaging, which must not however make us forget the basics of interventional cardiology, before attending the prize-giving ceremony for the best clinical cases...

GulfPCR-GIM 2022 - Closing Ceremony

Rapid-Fire clinical cases: Session 3

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of clinical cases presented during PCR LV 2022: tunnel stent technique as an alternative treatment for left main protection in valve-in-valve TAVI, coronary embolisation due to valve-in-valve aortic prothesis thrombosis, aortic prosthetic valve dysfunction due to endocarditis, and more!

Rapid-Fire clinical cases: Session 3

How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair

28 Nov 2022 – From PCR London Valves 2022

Consul this session to learn more about the available treatment options after failed mitral surgical or transcatheter procedures, the factors that increase the likelihood of residual/recurrent mitral regurgitation, and more!

How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair

The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis

18 May 2022 – From EUROPCR 2022

This session from EuroPCR 2022 will help you understand how the first bioprosthetic aortic valve may affect long-term outcomes of patients with aortic stenosis. Learn how to optimise their lifetime management and how to refine procedural steps during TAVI.

The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis

Advances in renal denervation: from patient selection to procedure

17 May 2022 – From EuroPCR 2022

For this EuroPCR 2022 session, Felix Mahfoud is joined by David Kandzari, Rasha Al-Lamee, Flavio Ribichini, and Andrew Sharp to talk about renal denervation: hear real-life experiences and get the latest preclinical and clinical data on the long-term safety and efficacy of the radiofrequency renal denervation...

Advances in renal denervation: from patient selection to procedure

Valve-in-valve: the journey starts with the first prosthesis

17 May 2022 – From EuroPCR 2022

In this EuroPCR 2022 session featuring Philip Maccarthy, Julia Mascherbauer, Hendrik Treede, Christian Hengstenberg, Radoslaw Parma, and Giuseppe Tarantini, analyze the impact of valve-in-valve interventions on lifetime management, learn about particular clinical considerations and the procedural technique of TAVI-in-TAVI procedures, and appreciate the potential pitfalls of...

Valve-in-valve: the journey starts with the first prosthesis

The cathlab of the future

17 May 2022 – From EuroPCR 2022

Let's take the practical case of an 84-year-old male patient with hypertension, dyslipidaemia, and severe aortic stenosis: in this EuroPCR 2022 session, find out how to treat such a patient in the cathlab of the future and discuss the benefits of non-invasive technology at tableside, tools...

The cathlab of the future

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation

Towards a personalised coronary intervention with CT-guided robotic-assisted PCI

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session aims to show how coronary CT angiography can help in pre-procedural planning and guidance of PCI to achieve the best patient outcomes. It also explores the role of robotic-assisted PCI in improving procedural accuracy, radiation safety, and ergonomics within the cathlab. Finally, it demonstrates how...

Towards a personalised coronary intervention with CT-guided robotic-assisted PCI

Start treating refractory angina patients with Reducer therapy - Practical aspects

17 May 2022 – From EuroPCR 2022

Looking at a 75-year-old male patient with HTA, diabetes, and hypothyroidism, a history of coronary artery disease treated with PCI of the RCA, and a previous coronary angiography showing preserved LVEF and in-stent restenosis of the RCA, you will learn in this EuroPCR 2022 session how...

Start treating refractory angina patients with Reducer therapy - Practical aspects

DCB and the possibility of a clean vessel

17 May 2022 – From EuroPCR 2022

This EuroPCR 2022 session aims to show, based on real-life cases, that even complex coronary disease can be treated without the need for permanent coronary stents. Learn how to prepare the vessel, deliver the therapy, and assess immediate outcomes after "DCB-alone" PCI, discuss de novo, small vessels, and...

DCB and the possibility of a clean vessel

2022: a tipping point in the treatment of mitral regurgitation patients

17 May 2022 – From EuroPCR 2022

With study outcomes and clinical cases, this EuroPCR 2022 session will enable you to discuss the anatomical considerations that define suitable candidates for treatment of mitral regurgitation with the PASCAL platform and highlight key differentiators and tips and tricks for its use.

2022: a tipping point in the treatment of mitral regurgitation patients
Didn’t find what you were looking for?